Recognify Life Sciences, a company Atai Life Sciences is a strategic investor in, said its trial for a cognitive decline treatment missed its primary endpoint. Atai shares fell 13% to $3.08 in ...

While most commercial office landlords are still hunting for post‑pandemic tenants, there's a sector of the real estate industry that's breeding breakout growth: life sciences. Global biotech spending ...

Genmab A/S (NASDAQ: GMAB) is one of the most profitable biotech stocks to invest in now. In a report released on July 14, Yaron Werber from TD Cowen maintained a Hold rating on Genmab A/S (NASDAQ:GMAB ...

A majority of Americans have experienced the frustration of getting a healthcare insurance denial, often times finding no ...

A significant trading signal occurred for Netflix stock, as it demonstrated a power inflow at $1164.91, after which NFLX rose ...

Shares of Intel Corporation declined over 7% in Friday pre-market, after its Q2 earnings per share (EPS) that fell short of expectations.

Contract research organizations are reporting better-than-expected second-quarter profit, a sign that Wall Street analysts ...

Second-quarter earnings come amid many high-level challenges for the biopharma industry. How will these five closely watched ...

It’s one of the most explosive sectors in the market — but also one of the riskiest. Biotech investors, beware. Small-cap biotech stocks can be extremely volatile… but if you know what to look for, ...

Looking for hot penny stocks? AIRE, PMN, and IXHL surged with heavy volume. Here’s why these three are top penny stocks to ...

Alphabet, UnitedHealth Group, and Oracle are the three Healthcare stocks to watch today, according to MarketBeat's stock ...

Michelle Xia gained experience at U.S. pharmaceutical firms before launching her own biotech company back home in China. In a ...